Worth reading
69In focus
Scored from 3 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
4559000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 22nd Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions)
発行・処分する株式数
Shares delivered during the month: 4,559,000 shares (new shares: 4,559,000; treasury shares transferred: 0)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Existing Shares and Increase
+10.00%Rate of increase
46,323,560 shares50,882,560Shares
Exercise ratio subject to exercise restrictions: 10.0%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the relevant month: ¥27.00–¥34.00 per share. Details and floor of the adjustment provisions: not disclosed
Number of Stock Acquisition Rights
Total issued: 210,000 rights; exercised during the relevant month: 45,590 rights; unexercised at the end of the preceding month: 202,700 rights; unexercised at month-end: 157,110 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
13 May 2026: Issuance of the 22nd Series Stock Acquisition Rights (total issued: 210,000 rights)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 22nd Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 4,559,000 shares (new shares: 4,559,000; treasury shares transferred: 0) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 10.0% |
| Total number of issued shares | 46,323,560 shares (as of the end of the month preceding the relevant month) → 50,882,560 shares (calculated figure as of the end of the relevant month) |
| Exercise price | Exercise price during the relevant month: ¥27.00–¥34.00 per share. Details and floor of the adjustment provisions: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 210,000 rights; exercised during the relevant month: 45,590 rights; unexercised at the end of the preceding month: 202,700 rights; unexercised at month-end: 157,110 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 13 May 2026: Issuance of the 22nd Series Stock Acquisition Rights (total issued: 210,000 rights) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.